Deep dermal injection of non-absorbable gel polymer for HIV-related lipoatrophy

Recommendation ID: IPG439/1
Question: Further research and publication of observational data would be useful. Publications should describe details of patient selection, particularly in relation to previous treatments. They should also describe clinical outcomes (including all complications) and patient experience in the longer term. NICE may review the procedure on publication of further evidence.
Any explanatory notes (if applicable): Current evidence on the efficacy of deep dermal injection of non-absorbable gel polymer (NAGP) for HIV-related facial lipoatrophy is adequate. With regard to safety, infections that may need surgical removal of the implant are a risk in the longer term and other complications, including granuloma formation and migration, are common. Therefore, this procedure should be performed only with special arrangements for clinical governance, consent and audit or research.

Source guidance details

Comes from guidance: Deep dermal injection of non-absorbable gel polymer for HIV-related lipoatrophy
Number: IPG439
Date issued: January 2013

Is this a recommendation for the use of a technology only in the context of research?	No
Is it a recommendation that suggests collection of data or the establishment of a register?	No
Last Reviewed	30/01/2013